pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
BX-211
Diabetic Foot Infection (DFI)
$PHGEBiomX Inc.
0 catalysts
Phase 2
BXQ-350
Metastatic Colorectal Cancer
Bexion Pharmaceuticals Inc
0 catalysts
Phase 2
Base-Edited Hematopoietic Stem and Progenitor Cells
Chronic Granulomatous Disease
The National Institute of Allergy and Infectious Diseases
0 catalysts
Phase 2
Bria-OTS
← prev
page 8 of 50
next →
131
Pain89
Neurology1
Lung Cancer
$BCTXBriaCell Therapeutics Corp.
0 catalysts
Phase 2
Broncho-Vaxom
Wheezing
OM Pharma Ltd
0 catalysts
Phase 2
C-1205
Urinary Tract Infections Due To Catheter Encrustation
Atterx Biotherapeutics Inc
0 catalysts
Phase 2
CA-002
Peanut Allergy
Cambridge Allergy Ltd
0 catalysts
Phase 2
CAL-02
Community-Acquired Bacterial Pneumonia
Eagle Pharmaceuticals Inc
0 catalysts
Phase 2
CAL-101
Idiopathic Pulmonary Fibrosis
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
Calluna Pharma AS
0 catalysts
Phase 2
CAM-101
Elate Ocular
Keratoconjunctivitis Sicca (Dry Eye)
Cambium Bio Limited
0 catalysts
Phase 2
CBL-514
Adiposis Dolorosa (Dercum's Disease or Anders Disease)
Caliway Biopharmaceutics Co Ltd
0 catalysts
Phase 2
CBP-1019
Breast Cancer
Coherent Biopharma
0 catalysts
Phase 2
CBP-501
Pancreatic Cancer
CanBas Co Ltd
0 catalysts
Phase 2
CBT-004
Unspecified Ophthalmological Disorders
Cloudbreak Therapeutics LLC
0 catalysts
Phase 2
CBT-006
Keratoconjunctivitis Sicca (Dry Eye)
Cloudbreak Therapeutics LLC
0 catalysts
Phase 2
CBX-12
Colorectal Cancer
Cybrexa Inc
0 catalysts
Phase 2
CDI-988
Norovirus Infections
$COCPCocrystal Pharma, Inc.
0 catalysts
Phase 2
CEP-11981
Pancreatic Cancer
Vascular endothelial growth factor receptorAngiopoietin-1 receptor
$TEVATEVA PHARMACEUTICAL INDUSTRIES LTD
0 catalysts
Phase 2
CER-1236
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
$CEROCERO THERAPEUTICS HOLDINGS, INC.
0 catalysts
Phase 2
CFI-402411
Anal Cancer
Treadwell Therapeutics Inc
0 catalysts
Phase 2
CHF-6333
Bronchiectasis
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
CHM-2101
Colon Cancer
Chimeric Therapeutics Ltd
0 catalysts
Phase 2
CHOH-01
B-Cell Non-Hodgkin Lymphoma
CHO Pharma Inc
0 catalysts
Phase 2
CID-103
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
$CASIFCASI Pharmaceuticals, Inc.
0 catalysts
Phase 2
CLIO-8221
Solid Tumor
Callio Therapeutics Inc
0 catalysts
Phase 2
CLR-121125
Triple-Negative Breast Cancer (TNBC)
$CLRBCellectar Biosciences, Inc.
0 catalysts
Phase 2
CM-4612
Attention Deficit Hyperactivity Disorder (ADHD)
Curemark LLC
0 catalysts
Phase 2
CMND-100
Alcohol Use Disorder (AUD)
$CMNDClearmind Medicine Inc.
0 catalysts
Phase 2
CMTX-101
Pseudomonas aeruginosa Infections
Clarametyx Biosciences Inc
0 catalysts
Phase 2
CN-105
Intracerebral Hemorrhage
AegisCN LLC
0 catalysts